Related Experiment Video
Updated: Jun 28, 2026
Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
Published on: October 17, 2018
Efficacy Evaluation of Virus Clearance of SYN023 in A Murine Rabies Model - China, 2025
Yixiang Ma1, Zixin Fang2, Xiaoyan Tao2
1Emergency Department of Peking University First Hospital, Beijing, China.
What Is Already Known About This Topic?:
Rabies is a fatal, but preventable, viral disease. Post-exposure prophylaxis (PEP), which includes the administration of passive immune preparations, is critical after exposure to the rabies virus, particularly in high-risk cases. The delayed or missed application of passive immunizing agents may increase the risk of infection.
What Is Added By This Report?:
SYN023, a novel anti-rabies monoclonal antibody cocktail, can effectively reverse the course of rabies infection, even at a late stage of the disease. In a mouse model infected with the rabies virus strain SC16, multiple high-dose injections of SYN023 administered 5 days post-inoculation rescued 69% of the animals.
What Are The Implications For Public Health Practice?:
These findings suggest that SYN023 could serve as a promising therapeutic agent for rabies PEP, particularly in cases in which treatment initiation is delayed. This study provides a scientific basis for future clinical trials aimed at improving rabies treatment protocols.
